OMB Control No: 0970-0509
Expiration date: 09/30/2026
Public Health Investigation Form: Active TB Unaccompanied Alien Children Bureau Office of Refugee Resettlement (ORR) |
|||||||||||||||||||||||||||||
General Information |
|||||||||||||||||||||||||||||
Child
|
Last name: |
First name:
|
|||||||||||||||||||||||||||
DOB:
|
A#:
|
Sex: |
|||||||||||||||||||||||||||
Program |
Program name:
|
Person completing form & date:
|
|||||||||||||||||||||||||||
Exposure Information |
|||||||||||||||||||||||||||||
Source of potential exposure (e.g., staff member, other UC): ____________________________________________________________ |
|||||||||||||||||||||||||||||
Date of first potential exposure: ____ / ____ / ______ |
Date of last potential exposure: ____ / ____ / ______ |
||||||||||||||||||||||||||||
Exposure details (e.g., child was potentially exposed for 4 hours a day in class for 5 consecutive days):
|
|||||||||||||||||||||||||||||
Was child screened for active TB signs/symptoms upon notification of exposure? |
|
|
|||||||||||||||||||||||||||
If screened, did child have active TB signs/symptoms? |
|
|
|||||||||||||||||||||||||||
If Yes, was child evaluated by a healthcare provider? |
|
|
|||||||||||||||||||||||||||
Public Health Actions |
|||||||||||||||||||||||||||||
Select No or Yes for each question below. If Yes, enter the information in the corresponding table. |
|||||||||||||||||||||||||||||
PPD/Tuberculin skin test (TST): |
|
|
|||||||||||||||||||||||||||
Date Applied |
Date Read |
Reaction (mm) |
Result |
||||||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
TB blood test (Interferon-Gamma Release Assay [IGRA]): |
|
|
|||||||||||||||||||||||||||
Test type (Quantiferon or T-Spot) |
Collection Date |
Result |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
Imaging study: |
|
|
|||||||||||||||||||||||||||
Imaging Study Type (e.g., 2-view) |
Date Performed |
Findings (Normal or Abnormal) |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
Medications given: |
|
|
|||||||||||||||||||||||||||
Medication name |
Date started |
Date discontinued |
Dose |
Directions |
Psychotropic |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||||
Outcome of ORR public health investigation: |
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
Comments: |
|||||||||||||||||||||||||||||
|
The purpose of this information collection is to provide ORR with critical health information for unaccompanied children in the care of ORR. Public reporting burden for this collection of information is estimated to average 5 minutes per healthcare provider, including the time for reviewing instructions, gathering and maintaining the data needed, and reviewing the collection of information. This is a mandatory collection of information (6 U.S.C. §279: Exhibit 1, part A.2 of the Flores Settlement Agreement (Jenny Lisette Flores, et al., v. Janet Reno, Attorney General of the United States, et al., Case No. CV 85-4544-RJK [C.D. Cal. 1996]). An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information subject to the requirements of the Paperwork Reduction Act of 1995, unless it displays a currently valid OMB control number. The OMB # is 0970-0509 and the expiration date is 09/30/2026. If you have any comments on this collection of information, please contact [email protected].
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Buckley, Kirsten (CDC/OID/NCEZID) |
File Modified | 0000-00-00 |
File Created | 2025-02-17 |